Header Logo

Connection

Gomika Udugamasooriya to Humans

This is a "connection" page, showing publications Gomika Udugamasooriya has written about Humans.
Connection Strength

0.448
  1. A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells. Bioorg Chem. 2021 11; 116:105340.
    View in: PubMed
    Score: 0.075
  2. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Int J Mol Sci. 2021 Aug 20; 22(16).
    View in: PubMed
    Score: 0.075
  3. Design of a dual ERK5 kinase activation and autophosphorylation inhibitor to block cancer stem cell activity. Bioorg Med Chem Lett. 2020 Dec 01; 30(23):127552.
    View in: PubMed
    Score: 0.070
  4. Identification of side arm-modified DOTA scaffolds as multi-site binding ligands for cancer cells over normal cells. Bioorg Med Chem Lett. 2019 Oct 01; 29(19):126619.
    View in: PubMed
    Score: 0.065
  5. A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1. Eur J Med Chem. 2017 Sep 08; 137:1-10.
    View in: PubMed
    Score: 0.056
  6. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1. Biochem Biophys Res Commun. 2017 Apr 29; 486(2):545-550.
    View in: PubMed
    Score: 0.055
  7. Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1. Bioorg Med Chem. 2016 Sep 15; 24(18):4470-4477.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.